No Data
No Data
Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025
Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $19
Express News | Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum
Is Syndax Pharmaceuticals (NASDAQ:SNDX) A Risky Investment?
Syndax's Revuforj Earns Strong Physician Support, JP Morgan Predicts Sales Growth